immune system
|
• in the peripheral blood
|
hematopoietic system
|
• in the peripheral blood
|
Analysis Tools|
Allele Symbol Allele Name Allele ID |
Prkdc+ wild type MGI:2433282 |
||||||||||||||||||||||||||||||||||||
| Summary |
8 genotypes
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• in the peripheral blood
|
|
• in the peripheral blood
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• increased T-independent antibody response to 4-hydroxy-3-nitrophenylacetyl-Ficoll (NP-Ficoll)
|
|
• increased T-independent antibody response to 4-hydroxy-3-nitrophenylacetyl-Ficoll (NP-Ficoll)
|
|
• increased T-independent antibody response to 4-hydroxy-3-nitrophenylacetyl-Ficoll (NP-Ficoll)
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• in the peripheral blood after mouse cytomegalovirus (MCMV) infection
|
|
• in the peripheral blood after mouse cytomegalovirus (MCMV) infection
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• after mouse cytomegalovirus (MCMV) infection
|
|
• B cells, IgD+ B cells, and IgM+ B cells in the peripheral blood after mouse cytomegalovirus (MCMV) infection
|
|
• after mouse cytomegalovirus (MCMV) infection
|
|
• after mouse cytomegalovirus (MCMV) infection
|
|
• after mouse cytomegalovirus (MCMV) infection
|
|
• B cells, IgD+ B cells, and IgM+ B cells in the peripheral blood after mouse cytomegalovirus (MCMV) infection
|
|
• after mouse cytomegalovirus (MCMV) infection
|
|
• after mouse cytomegalovirus (MCMV) infection
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• mild hyperpigmentation of the footpad in mice over 2 months of age
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• end to end chromosome fusions occur in about 1.6 out of 100 metaphases
• chromosome fusions involve random chromosomes
|
|
• telomeres are significantly shorter than in doubly heterozygous controls but there is always a detectable telomere
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• survival time at which half of the mutants are sacrificed or die due to illness is 183 days
|
|
• 60% incidence of thymoma
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• survival time at which half of the mutants are sacrificed or die due to illness is 183 days
|
|
• 93% incidence of thymoma
|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 01/20/2026 MGI 6.24 |
|
|
|
||


